• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于结构的诺如病毒 3CL 蛋白酶二肽抑制剂优化。

Structure-Guided Optimization of Dipeptidyl Inhibitors of Norovirus 3CL Protease.

机构信息

Department of Chemistry, Wichita State University, Wichita, Kansas 67260, United States.

Department of Diagnostic Medicine & Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, Kansas 66506, United States.

出版信息

J Med Chem. 2020 Oct 22;63(20):11945-11963. doi: 10.1021/acs.jmedchem.0c01252. Epub 2020 Oct 2.

DOI:10.1021/acs.jmedchem.0c01252
PMID:32945669
Abstract

Acute gastroenteritis caused by noroviruses has a major impact on public health worldwide in terms of morbidity, mortality, and economic burden. The disease impacts most severely immunocompromised patients, the elderly, and children. The current lack of approved vaccines and small-molecule therapeutics for the treatment and prophylaxis of norovirus infections underscores the need for the development of norovirus-specific drugs. The studies described herein entail the use of the -dimethyl moiety as a means of improving the pharmacological activity and physicochemical properties of a dipeptidyl series of transition state inhibitors of norovirus 3CL protease, an enzyme essential for viral replication. Several compounds were found to be potent inhibitors of the enzyme in biochemical and cell-based assays. The pharmacological activity and cellular permeability of the inhibitors were found to be sensitive to the location of the -dimethyl group.

摘要

诺如病毒引起的急性肠胃炎在发病率、死亡率和经济负担方面对全球公共卫生有重大影响。该疾病对免疫功能低下的患者、老年人和儿童的影响最为严重。目前尚无批准的疫苗和小分子疗法用于治疗和预防诺如病毒感染,这凸显了开发诺如病毒特异性药物的必要性。本文所述的研究使用二甲基取代基作为提高一系列二肽基过渡态抑制剂对诺如病毒 3CL 蛋白酶的药理学活性和物理化学性质的手段,该酶是病毒复制所必需的。在生化和基于细胞的测定中,发现几种化合物是该酶的有效抑制剂。抑制剂的药理学活性和细胞通透性对二甲基取代基的位置敏感。

相似文献

1
Structure-Guided Optimization of Dipeptidyl Inhibitors of Norovirus 3CL Protease.基于结构的诺如病毒 3CL 蛋白酶二肽抑制剂优化。
J Med Chem. 2020 Oct 22;63(20):11945-11963. doi: 10.1021/acs.jmedchem.0c01252. Epub 2020 Oct 2.
2
Oxadiazole-Based Cell Permeable Macrocyclic Transition State Inhibitors of Norovirus 3CL Protease.基于恶二唑的诺如病毒3CL蛋白酶细胞可渗透大环过渡态抑制剂
J Med Chem. 2016 Mar 10;59(5):1899-913. doi: 10.1021/acs.jmedchem.5b01464. Epub 2016 Feb 8.
3
Structure-based exploration and exploitation of the S subsite of norovirus 3CL protease in the design of potent and permeable inhibitors.基于结构的诺如病毒3CL蛋白酶S亚位点的探索与利用以设计强效且可渗透的抑制剂。
Eur J Med Chem. 2017 Jan 27;126:502-516. doi: 10.1016/j.ejmech.2016.11.027. Epub 2016 Nov 14.
4
Structure-guided design and optimization of dipeptidyl inhibitors of norovirus 3CL protease. Structure-activity relationships and biochemical, X-ray crystallographic, cell-based, and in vivo studies.诺如病毒3CL蛋白酶二肽基抑制剂的结构导向设计与优化。构效关系以及生化、X射线晶体学、细胞水平和体内研究。
J Med Chem. 2015 Apr 9;58(7):3144-55. doi: 10.1021/jm5019934. Epub 2015 Mar 19.
5
Synthesis and antiviral evaluation of novel peptidomimetics as norovirus protease inhibitors.新型拟肽作为诺如病毒蛋白酶抑制剂的合成及抗病毒评价
Bioorg Med Chem Lett. 2018 Jul 1;28(12):2165-2170. doi: 10.1016/j.bmcl.2018.05.012. Epub 2018 May 8.
6
Structure-based design and synthesis of triazole-based macrocyclic inhibitors of norovirus protease: Structural, biochemical, spectroscopic, and antiviral studies.基于结构的诺如病毒蛋白酶三唑基大环抑制剂的设计与合成:结构、生化、光谱及抗病毒研究
Eur J Med Chem. 2016 Aug 25;119:300-18. doi: 10.1016/j.ejmech.2016.04.013. Epub 2016 Apr 25.
7
Structure-guided design, synthesis and evaluation of oxazolidinone-based inhibitors of norovirus 3CL protease.基于结构的诺如病毒3CL蛋白酶恶唑烷酮类抑制剂的设计、合成与评价
Eur J Med Chem. 2018 Jan 1;143:881-890. doi: 10.1016/j.ejmech.2017.12.014. Epub 2017 Dec 6.
8
Inhibition of norovirus 3CL protease by bisulfite adducts of transition state inhibitors.亚硫酸盐过渡态抑制剂加成物对诺如病毒 3CL 蛋白酶的抑制作用。
Bioorg Med Chem Lett. 2013 Jan 1;23(1):62-5. doi: 10.1016/j.bmcl.2012.11.026. Epub 2012 Nov 21.
9
Design, synthesis, and evaluation of a novel series of macrocyclic inhibitors of norovirus 3CL protease.新型诺如病毒3CL蛋白酶大环抑制剂的设计、合成与评价
Eur J Med Chem. 2017 Feb 15;127:41-61. doi: 10.1016/j.ejmech.2016.12.033. Epub 2016 Dec 21.
10
Potent inhibition of norovirus by dipeptidyl α-hydroxyphosphonate transition state mimics.二肽 α-羟基膦酸过渡态类似物强效抑制诺如病毒。
Bioorg Med Chem Lett. 2013 Nov 1;23(21):5941-4. doi: 10.1016/j.bmcl.2013.08.073. Epub 2013 Aug 22.

引用本文的文献

1
Discovery of Small Molecules Targeting Norovirus 3CL Protease by Multi-Stage Virtual Screening.通过多阶段虚拟筛选发现靶向诺如病毒3CL蛋白酶的小分子
Int J Mol Sci. 2025 Jun 12;26(12):5625. doi: 10.3390/ijms26125625.
2
On the origins of SARS-CoV-2 main protease inhibitors.关于严重急性呼吸综合征冠状病毒2主要蛋白酶抑制剂的起源
RSC Med Chem. 2023 Oct 13;15(1):81-118. doi: 10.1039/d3md00493g. eCollection 2024 Jan 25.
3
Crystal Structure of Inhibitor-Bound GII.4 Sydney 2012 Norovirus 3C-Like Protease.抑制剂结合的 GII.4 悉尼 2012 年诺如病毒 3C 样蛋白酶的晶体结构。
Viruses. 2023 Oct 31;15(11):2202. doi: 10.3390/v15112202.
4
P Glutamine isosteres in the design of inhibitors of 3C/3CL protease of human viruses of the class.人γ冠状病毒3C/3CL蛋白酶抑制剂设计中的P谷氨酰胺等排体
RSC Chem Biol. 2023 Jun 21;4(8):533-547. doi: 10.1039/d3cb00075c. eCollection 2023 Aug 3.
5
Design, synthesis and in vitro evaluation of novel SARS-CoV-2 3CL covalent inhibitors.设计、合成新型 SARS-CoV-2 3CL 共价抑制剂,并进行体外评估。
Eur J Med Chem. 2022 Feb 5;229:114046. doi: 10.1016/j.ejmech.2021.114046. Epub 2021 Dec 11.
6
Current and Future Antiviral Strategies to Tackle Gastrointestinal Viral Infections.应对胃肠道病毒感染的当前及未来抗病毒策略
Microorganisms. 2021 Jul 27;9(8):1599. doi: 10.3390/microorganisms9081599.